Informed pharmaceutical sources revealed that the number of units sold in the Egyptian pharmaceutical market, during the first seven months of this year, through the “private sector” reached 1.305 billion units, a decline of 4.9%, and sales values of 46.1 billion Egyptian pounds.
The sources indicated, in exclusive statements that the Egyptian pharmaceutical market achieved sales in terms of the number of units during the month of July by about 177 million units, a decrease of 12%, with sales values of 6.272 billion pounds.
While it achieved sales during the period from June 2020 to June 2021, with 2.419 billion units, with sales values of 82.8 billion Egyptian pounds.
The Egyptian pharmaceutical market owns about 155 drug factories, in addition to 40 factories under construction, along with about 1,200 commercial companies that manufacture their products for others, and about 20 foreign drug companies operating in the market, whether through their factories in Egypt or through their scientific offices.
